<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>BAX on Deep Analyst AI</title><link>https://deepanalyst.ai/tags/BAX/</link><description>Recent content in BAX on Deep Analyst AI</description><generator>Hugo -- gohugo.io</generator><language>en-us</language><lastBuildDate>Mon, 02 Feb 2026 00:00:00 +0000</lastBuildDate><atom:link href="https://deepanalyst.ai/tags/BAX/rss.xml" rel="self" type="application/rss+xml"/><item><title>Code Blue: Why Baxter International is the Most Expensive 'Cheap' Stock on Wall Street</title><link>https://deepanalyst.ai/posts/2026/02/bax-code-blue-why-baxter-international-is-most-expensive-cheap-stock-wall-street/</link><pubDate>Mon, 02 Feb 2026 00:00:00 +0000</pubDate><guid>https://deepanalyst.ai/posts/2026/02/bax-code-blue-why-baxter-international-is-most-expensive-cheap-stock-wall-street/</guid><description>Code Blue: Why Baxter International is the Most Expensive &amp;lsquo;Cheap&amp;rsquo; Stock on Wall Street If irony were a tradable commodity, Baxter International (BAX) would currently be the most valuable company on Earth. Here we have a medical giant responsible for keeping patients alive, yet the corporation itself is gasping for air on its own gurney. We are looking at a legacy titan that has managed to make the defensive healthcare sector look like a masterclass in volatility.</description></item></channel></rss>